Tamsulosin HCl

8 Drugs classified under this active ingredient

5-α Reductase Inhibitor, α1 Blocker. Dutasteride 0.5 mg, Tamsulosin HCl 0.4 mg.
5-a Reductase Inhibitor/Alpha 1 Blocker. Dutasteride 0.5 mg, tamsulosin 0.4 mg.
CAPS: 30. 1 cap. dly. See lit.
Tmt. mod. to severe symp. BPH. Reduc. risk of acute urin. reten. (AUR) and surgery in pts. with mod. to severe sympt. of BPH.
C/I: Hyperses., women, child., adolesn., pts. with a hist. of orthost. hypotension, pts. with severe hepat. impair.

5-α Reductase Inhibitor, α1 Blocker. Dutasteride 0.5 mg, Tamsulosin HCl 0.4 mg.
CAPS: 30. 1 cap orally 30 mins. aft. same
meal each day.
Tmt. mod.-severe sympts. BPH. Reduct.
risk acute urin. retent. (AUR), surg. in pts.
with mod.-severe sympts. BPH.

α1 Blocker. Tamsulosin HCl 0.4 mg.
S.R. CAPS: 30. 1 cap dly aft. breakf. or
the 1st meal of the day.
Funct. sympts. BPH.

α1 Blocker. Tamsulosin HCl 0.4 mg.
PROLONG. RELEASE F.C. TABS: 30. 1 tab
dly independ. food. Swallow whole.
Lower urin. tract sympts. (LUTS) assoc.
with BPH.

α1 Blocker. Tamsulosin HCl 0.4 mg.
CAPS: 30. 1 cap. dly aft. breakf., taken
standing.
Funct. sympts. BPH.
C/I: Hypersens., orthostat. hypotens.,
severe hepat. insuffic.

α1 Blocker. Tamsulosin HCl 0.4 mg.
P.R. TABS: 30 x 0.4 mg. Adults: 1 tab. × 1/d, independ. of food.
LUTS assoc. with BPH.
C/I: Hypersens. History of orthos.
hypotens. Severe hep. insuf.